Proactive Investors - Run By Investors For Investors

Neovasc shares pop after Edwards Lifesciences settles patent infringement case

The action, which was settled on a no-costs basis, had previously been lodged in the Federal Court of Canada against Neovasc, Boston Scientific and Livanova
patents filing
Neovasc's products include the Neovasc Reducer for the treatment of refractory angina

Neovasc Inc (NASDAQ:NVCN) said Tuesday it has won a victory as Edwards Lifesciences (NYSE:EW) has settled its patent infringement action in Canada against the medical device company on a no-costs basis.

The lawsuit had previously been lodged in the Federal Court of Canada against Neovasc, Boston Scientific Corp (NYSE:BSX) and Livanova plc.

Investors welcomed the legal advance, sending Neovasc shares up 9.5% to $0.82 in Tuesday afternoon trading.

READ: Neovasc shares pop on live viewing of implantation of Tiara mitral valve replacement device

Headquartered in Vancouver, Neovasc makes products to correct deficiencies in the heart. 

Its products include the Neovasc Reducer for the treatment of refractory angina, and the Tiara, a transcatheter device that treats mitral regurgitation, a heart condition that is often severe and can lead to heart failure.

The Neovasc Reducer is not currently commercially available in the US, but has been on the market in Europe since 2015. The Tiara, meanwhile, is under clinical investigation in the US, Canada and Europe.

Contact Ellen Kelleher at [email protected]

View full NVC profile View Profile

Neovasc Timeline

Related Articles

Scientist
December 03 2018
Since September, the group's portfolio has steamed ahead with a number of new and successful clinical trials, as well as a boost from the float of one of its companies on the Nasdaq
Weight loss
January 07 2019
A deal with Indian firm Zeon Lifesciences in January is the ninth deal the firm has secured for the weight loss product
Nemaura Medical Inc CEO Dr Faz Chowdhury
November 05 2018
The medtech company is eying explosive growth with sugarBEAT, on the cusp of launching in the UK, followed by the rest of Europe in 2018
Copyright © Proactiveinvestors.com, 2019. All Rights Reserved - Proactive Investors North America Inc., Proactive Investors LLC

Market Indices, Commodities and Regulatory News Headlines copyright © Morningstar. Data delayed 15 minutes unless otherwise indicated. Terms of use